Channel BannerChannel Banner
rHtehK2khYgrHtehK2khYg

Retatrutide vs Ozempic: The Results Are INSANE

57,479
Socialcounts.OrgEnter Fullscreen (f)
1,684
likes
126
comments
daily view 0
monthly view 0

Share

Live Analytics

Comments 0

Retatrutide vs Ozempic: The Results Are INSANE Analytics Table

Income Estimates for Retatrutide vs Ozempic: The Results Are INSANE

Based on this YouTube video's total view count of 57.4K views and industry-standard rates, the estimated total earning is $40 - $115 through ad revenue. Historical data is not yet available to calculate daily, weekly, or monthly averages.

About Retatrutide vs Ozempic: The Results Are INSANE

Explore Retatrutide vs Ozempic: The Results Are INSANE with 57,479 views, 1,684 likes, and 126 comments. Experience the impact of this video content that has captured audience attention.

Retatrutide Phase 3 results are finally here, and the weight loss numbers are INSANE. Could this experimental triple-agonist weight loss drug outperform Ozempic, Wegovy, Mounjaro, and Zepbound? In the Phase 3 results discussed here, involving approximately 2,300 participants over 80 weeks, retatrutide delivered an average 25% body weight reduction at the highest 12 mg dose. That's approximately 62 pounds for the average participant in the trial. Among participants who completed treatment, weight loss approached 30%. For comparison, previous clinical trials reported approximately 15% weight loss with semaglutide (Ozempic/Wegovy) and 21% with tirzepatide (Mounjaro/Zepbound). These are comparisons across separate trials, not direct head-to-head results. But retatrutide isn't just about weight loss. The research discussed in this video also examines improvements in knee pain and obstructive sleep apnea. However, side effects, dose reductions, increased heart rate, and unanswered long-term cardiovascular safety questions remain important considerations. Retatrutide targets three hormone receptors: GLP-1, GIP, and glucagon, making it different from existing GLP-1 medications. So is retatrutide the most powerful weight loss drug yet? Dr. Alex Tatem breaks down the clinical trial results, potential benefits, and what the science actually tells us. Subscribe for more peptide research, GLP-1 updates, medical science, and unhinged biochemistry. āš ļø Educational content only. Not medical advice. Retatrutide is investigational and not FDA-approved as of this video's publication.

About YouTube Real-Time View Count

With SocialCounts.org’s view counter, track your YouTube video’s live view count and YouTube likes count in real time with fast, reliable updates.

Watch every YouTube video live view count rise with our real-time YouTube views tracker—built for accuracy and minimal delay.

Follow YouTube real time views as they happen, using our dedicated view counter for YouTube videos.

Get up-to-date live view count on YouTube and see real-time growth with SocialCounts.org’s smart tracking tools.

Embed Widget

Parameters:

  • fullscreen=true - Fullscreen counter
  • graph=true - Live graph chart
  • counter=0/1/2 - Select counter (0=likes, 1=views, 2=comments)
URL

Click to copy the embed URL to your clipboard